Literature DB >> 11378365

MEK (MAPKK) inhibitors. Part 2: structure-activity relationships of 4-anilino-3-cyano-6,7-dialkoxyquinolines.

N Zhang1, B Wu, N Eudy, Y Wang, F Ye, D Powell, A Wissner, L R Feldberg, S C Kim, R Mallon, E D Kovacs, L Toral-Barza, C A Kohler.   

Abstract

A series of 4-anilino-3-cyano-6,7-dialkoxyquinolines with different substituents attached to the 4-anilino group has been prepared that are potent MEK (MAP kinase kinase) inhibitors. The best activity is obtained when a phenyl or a thienyl group is attached to the para-position of the aniline through a hydrophobic linker, such as an oxygen, a sulfur, or a methylene group. The most active compounds show low nanomolar IC(50)'s against MEK (MAP kinase kinase), and have potent growth inhibitory activity in LoVo cells (human colon tumor line).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378365     DOI: 10.1016/s0960-894x(01)00238-4

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways.

Authors:  Qiang Shen; Powel H Brown
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

2.  Protein and lipid kinase inhibitors as targeted anticancer agents of the Ras/Raf/MEK and PI3K/PKB pathways.

Authors:  Carlos García-Echeverría
Journal:  Purinergic Signal       Date:  2008-06-04       Impact factor: 3.765

Review 3.  Quinoline-Based Molecules Targeting c-Met, EGF, and VEGF Receptors and the Proteins Involved in Related Carcinogenic Pathways.

Authors:  Annamaria Martorana; Gabriele La Monica; Antonino Lauria
Journal:  Molecules       Date:  2020-09-18       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.